Case of carbon-ion radiation recall mucositis associated with anti-programmed cell death 1 treatment for paranasal sinuses melanoma

被引：2
|
作者：
Waki, Yuma [1 ]
Nobeyama, Yoshimasa [1 ]
Katsumata, Fuminori [1 ]
Koto, Masashi [2 ]
Asahina, Akihiko [1 ]
机构：
[1] Jikei Univ, Sch Med, Dept Dermatol, Tokyo 1058461, Japan
[2] Natl Inst Radiol Sci, Natl Inst Quantum & Radiol Sci & Technol, Dept Charged Particle Therapy Res, Chiba, Japan
来源：
JOURNAL OF DERMATOLOGY | 2021年 / 48卷 / 10期
关键词：
D O I：
10.1111/1346-8138.16052
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E502 / E503
页数：2
相关论文
共 50 条
  • [21] Ganglionar tuberculosis infection evolving to hemophagocytic lymphohistiocytosis after anti-programmed cell death 1 treatment for high-risk melanoma: a case report
    Costa, Cesar M.
    Gadotti, Luiza L.
    Seiwald, Maria C.
    Salgues, Alessandra C. R.
    Ganem, Fernando
    Nascimento, Ellen C. T.
    Uip, David E.
    Arrais-Rodrigues, Celso
    Munhoz, Rodrigo R.
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [22] Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy
    Marano, A. L.
    Clarke, J. M.
    Morse, M. A.
    Shah, A.
    Barrow, W.
    Selim, M. A.
    Hall, R. P., III
    Cardones, A. R.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (03) : 580 - 583
  • [23] Localized iatrogenic lichen nitidus following anti-programmed cell death 1 antibody treatment
    Ho, B.
    Akhras, V.
    Chong, H.
    Wijesuriya, N.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 17 - 17
  • [24] Pneumonitis in combined Anti-programmed Death-1 Immunotherapy and Radiation Therapy for Renal Cell Carcinoma
    Yu, Nathan Y.
    Deftos, Michael
    Wang, Clifford C.
    CUREUS, 2018, 10 (12):
  • [25] Treatment of Advanced Melanoma With Concurrent Radiation and Programmed Cell Death 1 Inhibitors
    Kropp, L.
    De Los Santos, J. F.
    Li, P.
    Mckee, S.
    Conry, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E754 - E755
  • [26] Intrinsic insulin secretion capacity might be preserved by discontinuing anti-programmed cell death protein 1 antibody treatment in "anti-programmed cell death protein 1 antibody-induced' fulminant type 1 diabetes
    Sakai, Gota
    Saito, Daigo
    Nakajima, Ritsuko
    Hatano, Masako
    Noguchi, Yuichi
    Kurihara, Susumu
    Katayama, Shigehiro
    Inoue, Ikuo
    Noda, Mitsuhiko
    Shimada, Akira
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (02) : 448 - 449
  • [27] Demographic Factors Associated with Toxicity in Patients Treated with Anti-Programmed Cell Death-1 Therapy
    Shah, Kaustav P.
    Song, Haocan
    Ye, Fei
    Moslehi, Javid J.
    Balko, Justin M.
    Salem, Joe-Elie
    Johnson, Douglas B.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (07) : 851 - 855
  • [28] Anti-programmed death 1 antibody in the treatment of coexistent Mycobacterium fortuitum and lung cancer: A case report
    Cui-Cui Zhang
    Peng Chen
    World Journal of Clinical Cases, 2022, (12) : 3801 - 3807
  • [29] Anti-programmed death 1 antibody in the treatment of coexistent Mycobacterium fortuitum and lung cancer: A case report
    Zhang, Cui-Cui
    Chen, Peng
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (12) : 3801 - 3807
  • [30] Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case report
    Martin-Liberal, Juan
    Furness, Andrew J. S.
    Joshi, Kroopa
    Peggs, Karl S.
    Quezada, Sergio A.
    Larkin, James
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (06) : 765 - 767
12345